Virtu Financial LLC Adial Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$0.21 - $0.37 $4,099 - $7,222	-19,521 Reduced 42.44%	26,473 $6,000
Q1 2023 May 01, 2023	SELL	$0.24 - $0.56 $9,938 - $23,190	-41,411 Reduced 47.38%	45,994 $16,000
Q4 2022 Feb 15, 2023	BUY	$0.2 - $0.31 $1,942 - $3,010	9,711 Added 12.5%	87,405 $19,000
Q3 2022 Nov 07, 2022	BUY	$0.03 - $0.58 $1,370 - $26,494	45,681 Added 142.7%	77,694 $27,000
Q2 2022 Aug 09, 2022	BUY	N/A	32,013 New	32,013 $43,000

Q3 2021 Nov 12, 2021	SELL	N/A	-31,038 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	N/A	31,038 New	31,038 $79,000
Q4 2020 Feb 24, 2021	SELL	N/A	-18,902 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	N/A	18,902 New	18,902 $42,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $28.2M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.